Malaseb

Quick links to important sections

Malaseb

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Malaseb

Quick Facts

Property Description
Active ingredient Chlorhexidine Gluconate, Miconazole Nitrate
Form Shampoo, Spray (Topical)
Pharmacological class Antimicrobial, Antifungal, Dermatologicals
Common use Surface microbial control (Veterinary)
Origin Synthetic/Derived

Pharmacological Classification and Composition

Malaseb is defined as a fixed-dose combination veterinary medicinal product that falls within the Dermatologicals pharmacotherapeutic category, designated exclusively for external application. Its identity is established by its two synthetic active components, which collectively assign it to both the Antimicrobial and Antifungal pharmacological classes.

The core composition features Chlorhexidine Gluconate, an antiseptic bisbiguanide, and Miconazole Nitrate, an azole derivative. The efficacy of combining these specific agents is supported by pharmacological data, as dual-action shampoos containing both Chlorhexidine and Miconazole are recognized for managing superficial skin infections in companion animals. This combination provides a comprehensive initial step to address skin issues caused by mixed bacterial and fungal overgrowth.

General Purpose of the Dual-Action Formula

The general purpose of Malaseb is to provide effective, simultaneous surface-level microbial control against both bacterial and fungal pathogens. The formulation’s dual-action, combining an antiseptic and an antifungal agent, is intended to reduce the burden of surface pathogens that commonly contribute to various dermatological issues. This comprehensive approach is designed to help stabilize the skin’s microbial environment. Furthermore, products with Miconazole and Chlorhexidine are classified as therapeutically appropriate for conditions caused by organisms sensitive to these active ingredients, establishing its role as a recognized agent for targeted decontamination in dogs, cats, and horses.

What side effects are possible with Malaseb?

Possible Side Effects and Safety Information

The official safety profile for Malaseb Shampoo is structured by frequency and site of adverse reactions as documented in regulatory sources.


Adverse Reaction Scope

The incidence of adverse events in the target species (dogs and cats) is formally classified as very rare, occurring in less than 1 animal per 10,000 animals treated. These reactions primarily fall under the category of Disorders of the Skin and Subcutaneous Tissue.

Category Description
Very Rare Reactions Application site erythema (redness), application site pruritus (itching), and general skin reaction.
Serious Reactions The active ingredient, Chlorhexidine Gluconate, is associated with reports of rare but serious allergic reactions.

Safety Considerations and Restrictions

Official labeling includes specific restrictions and population notes. Use is contraindicated in cases of known hypersensitivity to the active substances, Chlorhexidine or Miconazole, or to any of the product's excipients.

Population-Specific Notes:

  • Atopic and Allergic Animals: Dogs with atopy and cats with allergic skin disease may, on an exceptional basis, develop a pruritic or erythematous reaction following application.
  • Pregnant and Lactating Animals: Safety has not been definitively established during general pregnancy and lactation; use requires a benefit/risk assessment. The product is also contraindicated in pregnant cats if used in conjunction with the systemic antifungal drug, Griseofulvin.

Regulatory Summary

The regulatory framework establishes that the primary risk is the very rare occurrence of local skin irritation. The overall safety profile emphasizes the necessity of avoiding use where a hypersensitivity to either active agent exists, which is the most critical safety restriction defined in the official documents.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Malaseb, a topical veterinary product containing Chlorhexidine Gluconate and Miconazole Nitrate, strictly details the risks associated with accidental systemic exposure. The primary concern for overdose is related to circumstances that permit ingestion or deep ocular contact.

Feature Regulatory Documentation
Documented Overdose Presentations Symptoms documented following licking or ingestion include gastrointestinal tract irritation or respiratory tract irritation. A severe outcome cited for the active components is the risk of a severe allergic reaction (anaphylaxis).
Exposure-Related Factors Overdose risk is primarily constrained to accidental oral ingestion by animals or human handlers, specifically children. Regulators issue a specific warning that the product must be kept out of their reach.
Required Emergency Actions Immediate medical help must be sought following accidental ingestion or if irritation persists after accidental ocular exposure. Management is symptomatic and supportive, and official instructions state not to induce vomiting due to the risk of aspiration.

The regulatory documentation specifies that although systemic effects following ingestion are classified as generally unlikely due to poor absorption, the possibility of serious consequences like anaphylaxis from the active ingredients mandates strict emergency protocols. Urgent medical consultation is required to address the documented potential for severe outcomes and to ensure that only the regulator-defined symptomatic and supportive care is provided.

Therapeutic Uses of Malaseb

What Malaseb Treats: Main Uses and Benefits

The primary purpose of Malaseb is to address conditions involving inflammatory or irritative processes on the skin.

This topical treatment is commonly used in dogs and cats for the management of conditions such as seborrhoeic dermatitis and fungal infections like dermatophytosis (ringworm), which is relevant in managing infections involving Staphylococcus pseudintermedius and Malassezia pachydermatis.

The medication is relevant for easing symptoms related to physical discomfort, such as intense itchiness (pruritus) and redness, which are secondary manifestations of the underlying microbial involvement. The treatment is commonly used to help with symptomatic relief, which supports general well-being during symptomatic phases. It is applied in situations where additional symptomatic support is needed, and is relevant for easing symptoms related to scaling and greasiness.


“The therapy is used in situations involving certain distressing symptoms and the reduction of surface microbial load.”


Quick Fact: Relief for Pruritus and Scaling

Symptom Domain Therapeutic Benefit
Microbial Overgrowth Supports reducing the high load of surface pathogens.
Seborrhoeic Changes Assists with maintaining functional stability in the skin environment.
Itchiness (Pruritus) Contributes to improved comfort during symptomatic periods.

Regulatory References

  1. Summary of Product Characteristics filed with the UK VMD

Eligibility and Restrictions for Use

Who Can and Cannot Use Malaseb?

The official regulatory profile for Malaseb, a veterinary product, defines eligibility strictly by target species and specific clinical conditions.

Eligibility Scope Status as Stated in Label
Populations for whom use is allowed Dogs, Cats, and (in some jurisdictions) Horses. Includes puppies and kittens, subject to contact restrictions.
Populations for whom use is not recommended Rabbits and species other than dogs or cats.
Populations for whom use is contraindicated Animals with known hypersensitivity to the active substances (Chlorhexidine Gluconate, Miconazole Nitrate) or to any excipients.

Age, Pregnancy, and Condition-Specific Rules

Age-related eligibility rules: The product is permitted for use in puppies and kittens. However, regulatory documents require that they must not come into contact with nursing females after treatment until the animal’s coat has completely dried.

Pregnancy and lactation eligibility status: Use is prohibited in pregnant cats when receiving concomitant griseofulvin, as that drug is contraindicated in pregnancy. The safety of the shampoo has generally not been fully established in breeding, pregnant, or lactating animals.

Eligibility-context constraints: The constraints are species-specific, conditional (e.g., during lactation), and dependent on the animal’s allergic status to the components. The use of Malaseb is explicitly defined by these official restrictions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for this topical medicine specifies that no conventional interactions with other medicinal products are known. This classification includes the absence of documented pharmacokinetic (e.g., CYP-mediated) or pharmacodynamic interactions that would alter the effects or exposure of the product's active ingredients, consistent with its external application.

Interaction-Related Restrictions and Administration Rules

Official regulatory documents define the interaction profile primarily through required co-administration and related population constraints, rather than metabolic conflicts. The single explicitly defined restriction involves the systemic antifungal medicine, griseofulvin.


Interaction Type Requirement/Restriction as per Regulatory Label
Co-administration Rule Must be used in conjunction with griseofulvin when administering treatment for ringworm (dermatophytosis) in cats.
Contraindicated Combination The combination with griseofulvin is strictly prohibited in pregnant cats.

This mandatory co-administration rule applies exclusively to treating ringworm in cats. The resulting prohibition in pregnant cats is a specific, population-dependent restriction based on the safety profile of the co-administered griseofulvin, formally structuring the entire interaction landscape around this single combination therapy.

Mechanism of Action

How Malaseb Works

Malaseb is a dual-component topical product utilizing two active pharmaceutical ingredients, chlorhexidine gluconate and miconazole nitrate, which engage distinct mechanisms for a broader physiological effect profile.


Modulation of Bacterial Cell Integrity

Chlorhexidine gluconate, a bisbiguanide antiseptic, acts by disrupting the structural and functional components of bacterial cell membranes. This interaction initiates a molecular cascade beginning with the loss of low-molecular-weight cytoplasmic contents, leading to the eventual precipitation of the cell's internal material. The consequence is a rapid microbial action against Gram-positive and Gram-negative bacterial populations, resulting in a localized effect on microbial density.


Inhibition of Fungal Cell Membrane Synthesis

Miconazole nitrate, an imidazole antifungal agent, selectively targets the fungal enzyme lanosterol-14 alpha-demethylase. This enzyme is essential for the biosynthesis of ergosterol, a vital sterol required for fungal cell membrane structure. Inhibition of this enzyme leads to the accumulation of toxic C14-methylated sterols and impaired synthesis of ergosterol. The downstream effect is a disruption of membrane integrity and subsequent cellular leakage.

Dosage and Administration Information

Administration Scope (Shampoo Formulation)

Property Guideline
Route of Administration Topical (Cutaneous use).
Initial Frequency Twice weekly.
Maintenance Frequency Weekly or as necessary for ongoing management.
Required Contact Time 10 minutes (before rinsing).

Procedural Steps for Topical Use

Malaseb is applied as a shampoo according to a specific sequence, focusing on contact time and species-specific considerations.

Step Sequence:

  • Preparation: The animal's coat must be thoroughly wetted with clean water before application. The product should be shaken well prior to use.
  • Application: Apply a sufficient volume of the shampoo to create a lather across the entire coat and skin, ensuring coverage of areas such as around the lips, under the tail, and between the toes.
  • Contact: The lather must be allowed to remain on the animal for the required 10-minute contact time.
  • Rinse and Dry: The coat must be rinsed off thoroughly with clean water, followed by natural drying in a warm, draught-free environment.

Special Administration Contexts:

  • Specific Co-administration: For ringworm management in cats, the product should be used only in conjunction with griseofulvin.
  • Coat Management: Clipping the haircoat of the cat may be necessary prior to treatment, depending on hair length and type.
  • Young Animals: Puppies and kittens are directed not to come into contact with nursing females until the coat has completely dried after treatment.

Connection to the overall use protocol: This structured regimen defines a standardized topical application protocol centered on a mandatory 10-minute contact time and a specific frequency of use (twice weekly) for the initial phase. This process progresses from an intensive treatment schedule to an as-necessary maintenance pattern, following the instructions for the shampoo formulation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Malaseb

Evidence for Use in Seborrhoeic Dermatitis in Dogs

Studies have been conducted to evaluate the use of the Miconazole-Chlorhexidine combination in dogs diagnosed with seborrhoeic dermatitis, especially when the condition is associated with an overgrowth of Malassezia pachydermatis yeast and Staphylococcus bacteria. Research examined the measurement of these surface microbial populations over defined treatment periods.

The research monitored patterns observed in the surface microbial counts of the targeted organisms over the short-term treatment period (typically 3 to 6 weeks). Studies monitored outcomes linked to inflammatory states, such as pruritus (itching) and redness. Some comparative trials, where this combination was evaluated against other active topical ingredients, evaluated and reported on short-term measurements of clinical sign scores and microbial counts. Data for long-term disease management, recurrence rates, and sustained control beyond the initial study period are not fully established.

Evidence for Use in Dermatophytosis (Ringworm) in Cats

The use of this combination product for dermatophytosis (ringworm), primarily caused by Microsporum canis in cats, was evaluated as an aid or adjunctive treatment when used alongside a systemic antifungal medication. Research monitored outcomes such as the time required to achieve a consistently negative fungal culture, which is a measured outcome in studies of mycological clearance.

Studies conducted during periods of increased symptom activity reported that clearance was observed within the study window (typically 4 to 12 weeks) when the shampoo was used in conjunction with the systemic medication. Evidence is limited for the independent contribution or utility of the Miconazole-Chlorhexidine shampoo alone, as it is typically studied alongside the systemic drug.

What is Still Uncertain About the Research

The evidence landscape describes a few areas where more research is needed or where data remain insufficient. Sample sizes in some initial studies were modest, meaning results apply only to the specific populations studied. Furthermore, the certainty remains low regarding the utility of the topical product when used in isolation for severe fungal infections. Comparative evidence against newer topical agents is also lacking.

Key Studies & References

  1. Summary of Product Characteristics (SPC) - Malaseb Medicated Shampoo
  2. Efficacy of antifungal shampoos as adjuncts to systemic therapy in ringworm: A systematic review

Frequently Asked Questions (FAQ)

Common questions about Malaseb (FAQ)


Q: What specific skin conditions is Malaseb officially indicated for?

Malaseb is officially indicated for the treatment and control of seborrhoeic dermatitis when associated with the specific yeast Malassezia pachydermatis and Staphylococcus intermedius bacteria in dogs. Official documents also describe its use as an aid in treating ringworm (Microsporum canis) in cats, but only when used alongside a systemic antifungal medicine. This defines the product’s core treatment purposes.


Q: Is it common to see skin dryness or flakiness after using Malaseb?

Official regulatory documents classify skin redness (erythema) and itching (pruritus) at the application site as very rare adverse reactions, occurring in less than 1 in 10,000 animals treated. While dryness or flakiness are not specifically named, the overall safety profile indicates that local skin irritation is an uncommon occurrence.


Q: What warnings are listed about the risk of accidental ingestion or licking?

Official warnings advise that animals should not be left unattended during the 10-minute contact time or until the coat is dry. This is to prevent the animal from licking the product or inhaling the shampoo foam, as both actions are associated with a potential risk of irritation of the gastrointestinal or respiratory tracts.


Q: Are there any restrictions on who can or cannot handle the shampoo?

Regulatory documents advise that individuals with a known hypersensitivity (allergy) to the active ingredients (chlorhexidine, miconazole) or to any of the non-active excipients should avoid contact with the product. Standard caution is also advised, with instructions to wash hands after use.


Q: How long does the active component of Malaseb reportedly stay on the skin after rinsing?

Studies indicate that the active ingredients bind strongly to the hair and skin, allowing them to remain on the surface after rinsing. Pharmacokinetic data show that the active substances can be retained on the coat for a significant duration following the treatment procedure.


Q: What is the usual time frame mentioned in research for initial infection control with Malaseb?

Official guidance references use in active seborrhoeic dermatitis typically twice weekly for infection control. For ringworm in cats, clinical monitoring was over a period of 8 to 12 weeks when the shampoo was used as an aid to systemic therapy.


Q: What are the potential acute or delayed symptoms officially described for Miconazole Nitrate ingestion?

Official safety warnings indicate that accidental ingestion of the shampoo may lead to irritation of the gastrointestinal tract. This can potentially cause clinical signs such as vomiting or diarrhea, although the active ingredients are poorly absorbed internally.


Q: Are the active ingredients poorly absorbed from the skin, according to pharmacokinetics data?

Official pharmacokinetic data for the product confirms that both active components, Miconazole nitrate and Chlorhexidine digluconate, are poorly absorbed from the skin following topical application. This is consistent with its intended function as a surface-level antimicrobial product.


Q: Can Malaseb be used together with other topical skin products?

Official regulatory documents state that no conventional interactions with other medicinal products are known. There are no general prohibitions regarding its use with non-medicinal topical products.


Q: Are there any specific excipients (inactive ingredients) in Malaseb that are known allergens?

The official excipients list names specific substances, including Methylchloroisothiazolinone and Methylisothiazolinone. The product is formally contraindicated for use in animals with a known hypersensitivity to any of the product’s excipients, not just the active ingredients.


Q: Is Malaseb compatible with different coat types and lengths?

The procedural steps indicate that clipping the haircoat may be necessary prior to treatment to achieve adequate contact with the skin. This necessity is stated to depend on the hair length and type of the animal being treated.


Q: What is the significance of the 10-minute contact time for Malaseb to be effective?

The required 10-minute contact time is linked to the product’s efficacy. Official studies show that during this period, high concentrations of both active components are achieved on the skin. These concentrations are necessary to exceed the Minimum Inhibitory Concentrations (MICs) required to affect the targeted yeast and bacteria.


Q: How is Malaseb different from a standard cosmetic or grooming shampoo?

Malaseb is classified by regulatory authorities as a veterinary drug or medicinal product, intended to treat specific diseases caused by microbial overgrowth. This contrasts with a standard grooming or cosmetic shampoo, which is regulated differently and is solely intended for cleansing or enhancing appearance.


Q: What are the recommended steps if Malaseb accidentally contacts the eyes?

Official guidance indicates that in case of accidental eye contact, the area should be rinsed thoroughly and immediately with clean water. If irritation persists following this step, contacting a veterinarian or doctor is referenced in the safety documents.


Q: Is Malaseb considered toxic if a small amount is accidentally swallowed?

The active ingredients are described as poorly absorbed from the gastrointestinal tract, which generally limits systemic toxicity risk. However, accidental swallowing of the shampoo foam may still cause acute irritation of the gastrointestinal or respiratory tracts, potentially resulting in vomiting or diarrhea.


Q: Is Malaseb safe for use on localized skin areas or only the whole body?

The administration protocol in official documents references applying the product to create a lather across the entire coat and skin. This procedure ensures comprehensive coverage, especially of areas where microbial populations commonly flourish.


Q: Does Malaseb contain soap or detergent ingredients?

The product utilizes a specialized surfactant base, which includes ingredients like Cocamidopropyl Betaine. While it may be described as soap-free, these surfactants function as cleansing and lathering agents to distribute the active ingredients across the skin.


Q: What general steps are advised if skin irritation or a rash develops after using Malaseb?

Official caution warnings advise that if skin irritation develops or increases after use, the product should be discontinued. Consultation with a veterinarian is advised for follow-up guidance.


Q: Does the product description clarify how quickly the product is expected to begin working?

Official data shows that during the required 10-minute contact time, the concentrations of active ingredients exceed the Minimum Inhibitory Concentrations (MICs) needed to begin affecting the targeted microorganisms.


Q: Are there precautions mentioned regarding handling the product while pregnant?

Official warnings state that the use of rubber gloves by pregnant women is referenced in the handling precautions, along with avoiding contact with the skin and eyes. Hand washing is also advised after use.


Q: Does the official product information describe the scent of Malaseb?

The official product documentation specifies that the formula is fragrance-free. This means the product does not contain added perfumes or scents.


Q: Are there specific warnings about inhalation of Malaseb foam or vapor?

Safety warnings advise that users should avoid the animal inhaling the shampoo foam during bathing. Inhaling the foam may result in irritation of the gastrointestinal or respiratory tracts.


Q: Does the product documentation provide guidance on what to do if irritation persists?

The official caution warnings advise that if skin irritation persists or increases, the product should be discontinued immediately. Consulting a veterinarian is advised for follow-up guidance.


Q: What is the concentration of Miconazole Nitrate in the Malaseb formula?

The official regulatory profile states that the formula contains Miconazole nitrate at a concentration of 20 mg/ml. This concentration is consistent with its classification as a fixed-dose veterinary medicinal product.


Q: Is Malaseb available over-the-counter or only by prescription in most regions?

Official regulatory labeling in certain jurisdictions (such as the US) restricts this drug to use by or on the order of a licensed veterinarian. This classification indicates that the product is considered a prescription veterinary drug, though its exact availability status can vary by region.


Q: Does Malaseb treat the underlying cause of a skin condition or just the infection?

The primary function of the product is to reduce the burden of surface pathogens (bacteria and fungi) through its antimicrobial action. Official documents note that long-term therapy is often necessary because curing the underlying cause of the skin condition or microbial imbalance is not always possible with a topical treatment.

How should Malaseb be stored and disposed of?

Malaseb (Chlorhexidine Gluconate, Miconazole Nitrate) must be stored strictly according to the conditions outlined in regulatory labeling.

Storage Requirements

  • Temperature Restrictions: The product must be stored at room temperature, at a temperature not exceeding 30°C. It is mandatory that the medicine is not refrigerated or frozen and is stored in a manner that protects from freezing.
  • Product Stability: The shelf life for the unopened product is 2 years. Once the immediate packaging is first opened, the shelf life is 3 months.
  • Child Safety: The medicine must be kept out of the sight and reach of children.

Disposal Instructions

Disposal must comply with official instructions, which state that the medicine should not be disposed of via wastewater. Unused or expired product must be discarded in accordance with local requirements, typically by utilizing national take-back or collection schemes.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Malaseb found in:

A-Z Index: